Robustness Evaluation of Transactional Audio Watermarking Systems

Distribution via Internet is of increasing importance. Easy access, transmission and consumption of digitally represented music is very attractive to the consumer but led also directly to an increasing problem of illegal copying. To cope with this problem watermarking is a promising concept since it provides a useful mechanism to track illicit copies by persistently attaching property rights information to the material. Especially for online music distribution the use of so-called transaction watermarking, also denoted with the term bitstream watermarking, is beneficial since it offers the opportunity to embed watermarks directly into perceptually encoded material without the need of full decompression/compression. Besides the concept of bitstream watermarking, former publications presented the complexity, the audio quality and the detection performance. These results are now extended by an assessment of the robustness of such schemes. The detection performance before a nd after applying selected attacks is presented for MPEG-1/2 Layer 3 (MP3) and MPEG-2/4 AAC bitstream watermarking, contrasted to the performance of PCM spread spectrum watermarking

Mast Cells as Drivers of Disease and Therapeutic Targets

Mast cells (MCs) contribute to the pathogenesis of a multitude of diseases that include MC-driven disorders such as urticaria, type I allergies, and mastocytosis as well as autoimmune and other inflammatory disorders and malignant tumors. Here, we review and discuss the results of studies that identified and characterized how MCs contribute to disease and, importantly, what strategies may be used to target MCs and MC effects therapeutically. Specifically, we discuss the most common approaches for investigating the role and relevance of MCs in various diseases. We also review current therapeutic approaches aimed at modulating MC numbers, inhibiting MCs and/or preventing MC activation, modulating MC signal transduction and protection from the effects of MC mediators

Mast Cells as Drivers of Disease and Therapeutic Targets

Mast cells (MCs) contribute to the pathogenesis of a multitude of diseases that include MC-driven disorders such as urticaria, type I allergies, and mastocytosis as well as autoimmune and other inflammatory disorders and malignant tumors. Here, we review and discuss the results of studies that identified and characterized how MCs contribute to disease and, importantly, what strategies may be used to target MCs and MC effects therapeutically. Specifically, we discuss the most common approaches for investigating the role and relevance of MCs in various diseases. We also review current therapeutic approaches aimed at modulating MC numbers, inhibiting MCs and/or preventing MC activation, modulating MC signal transduction and protection from the effects of MC mediators